WealthTrust Axiom’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,691
Closed -$224K 268
2024
Q3
$224K Sell
11,691
-539
-4% -$11.2K 0.07% 225
2024
Q2
$253K Sell
12,230
-755
-6% -$15K 0.08% 194
2024
Q1
$244K Buy
12,985
+215
+2% +$3.69K 0.08% 204
2023
Q4
$184K Sell
12,770
-5,320
-29% -$72.4K 0.06% 224
2023
Q3
$314K Sell
18,090
-2,554
-12% -$53.3K 0.11% 163
2023
Q2
$430K Sell
20,644
-347
-2% -$7.54K 0.14% 150
2023
Q1
$494K Sell
20,991
-1,117
-5% -$30K 0.17% 122
2022
Q4
$618K Sell
22,108
-2,441
-10% -$62.4K 0.22% 98
2022
Q3
$574K Sell
24,549
-291
-1% -$8.79K 0.22% 98
2022
Q2
$838K Buy
24,840
+8,865
+55% +$310K 0.3% 75
2022
Q1
$557K Buy
15,975
+584
+4% +$20K 0.17% 120
2021
Q4
$468K Sell
15,391
-1,218
-7% -$39.7K 0.15% 134
2021
Q3
$544K Buy
+16,609
New +$531K 0.18% 113

Other funds holding OGN

WealthTrust Axiom's OGN Position: Q4 2024 in Review

WealthTrust Axiom sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 11,691 shares — an estimated $224K sold.

WealthTrust Axiom first reported a position in OGN in Q3 2021 and held it in 13 quarters. The position peaked at $838K in Q2 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • WealthTrust Axiom reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • WealthTrust Axiom sold 11,691 Organon & Co shares in Q4 2024, an estimated $224K.
  • WealthTrust Axiom first reported a position in Organon & Co in Q3 2021 and held it in 13 quarters.
  • WealthTrust Axiom's Organon & Co position peaked at $838K in Q2 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on WealthTrust Axiom's 13F filing for Q4 2024, filed 13 Feb 2025.